CN112063651A - Method for directionally editing common head cabbage gene by using CRISPR/Cas9 and application - Google Patents
Method for directionally editing common head cabbage gene by using CRISPR/Cas9 and application Download PDFInfo
- Publication number
- CN112063651A CN112063651A CN202010843518.7A CN202010843518A CN112063651A CN 112063651 A CN112063651 A CN 112063651A CN 202010843518 A CN202010843518 A CN 202010843518A CN 112063651 A CN112063651 A CN 112063651A
- Authority
- CN
- China
- Prior art keywords
- cas9
- common head
- crispr
- head cabbage
- editing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091033409 CRISPR Proteins 0.000 title claims abstract description 49
- 244000178937 Brassica oleracea var. capitata Species 0.000 title claims abstract description 37
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 32
- 238000010354 CRISPR gene editing Methods 0.000 title claims abstract description 25
- 239000013612 plasmid Substances 0.000 claims abstract description 42
- 241000196324 Embryophyta Species 0.000 claims abstract description 28
- 238000010362 genome editing Methods 0.000 claims abstract description 21
- 241000589158 Agrobacterium Species 0.000 claims abstract description 15
- 230000009466 transformation Effects 0.000 claims abstract description 10
- 238000001514 detection method Methods 0.000 claims abstract description 7
- 230000002068 genetic effect Effects 0.000 claims abstract description 7
- 238000003752 polymerase chain reaction Methods 0.000 claims description 29
- 238000012258 culturing Methods 0.000 claims description 22
- 239000002609 medium Substances 0.000 claims description 22
- 238000006243 chemical reaction Methods 0.000 claims description 20
- 239000001963 growth medium Substances 0.000 claims description 19
- 108020004414 DNA Proteins 0.000 claims description 17
- 239000000047 product Substances 0.000 claims description 17
- 239000012154 double-distilled water Substances 0.000 claims description 16
- 238000012163 sequencing technique Methods 0.000 claims description 16
- 230000001580 bacterial effect Effects 0.000 claims description 15
- 229920001817 Agar Polymers 0.000 claims description 14
- 239000008272 agar Substances 0.000 claims description 14
- 229960000723 ampicillin Drugs 0.000 claims description 14
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 241000588724 Escherichia coli Species 0.000 claims description 12
- 238000005286 illumination Methods 0.000 claims description 12
- 102000012410 DNA Ligases Human genes 0.000 claims description 11
- 108010061982 DNA Ligases Proteins 0.000 claims description 11
- 239000007795 chemical reaction product Substances 0.000 claims description 10
- 238000001976 enzyme digestion Methods 0.000 claims description 10
- 239000012634 fragment Substances 0.000 claims description 10
- 229930027917 kanamycin Natural products 0.000 claims description 10
- 229960000318 kanamycin Drugs 0.000 claims description 10
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 10
- 229930182823 kanamycin A Natural products 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 230000004069 differentiation Effects 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 claims description 5
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 102000003960 Ligases Human genes 0.000 claims description 4
- 108090000364 Ligases Proteins 0.000 claims description 4
- 230000003321 amplification Effects 0.000 claims description 4
- 239000003480 eluent Substances 0.000 claims description 4
- 230000035784 germination Effects 0.000 claims description 4
- 208000015181 infectious disease Diseases 0.000 claims description 4
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 4
- 239000012883 rooting culture medium Substances 0.000 claims description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 3
- 241000283690 Bos taurus Species 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 210000000813 small intestine Anatomy 0.000 claims description 3
- 241000589155 Agrobacterium tumefaciens Species 0.000 claims description 2
- 238000012408 PCR amplification Methods 0.000 claims description 2
- 239000012295 chemical reaction liquid Substances 0.000 claims description 2
- 239000012881 co-culture medium Substances 0.000 claims description 2
- 230000029087 digestion Effects 0.000 claims description 2
- 238000011160 research Methods 0.000 abstract description 6
- 108091027544 Subgenomic mRNA Proteins 0.000 abstract description 3
- 108700020796 Oncogene Proteins 0.000 abstract 1
- 102000043276 Oncogene Human genes 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 19
- 229930006000 Sucrose Natural products 0.000 description 12
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 12
- 229960004793 sucrose Drugs 0.000 description 12
- 239000005720 sucrose Substances 0.000 description 11
- 239000000843 powder Substances 0.000 description 10
- 238000000246 agarose gel electrophoresis Methods 0.000 description 7
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 6
- 229960001225 rifampicin Drugs 0.000 description 6
- 240000007124 Brassica oleracea Species 0.000 description 5
- 238000000137 annealing Methods 0.000 description 5
- 238000004925 denaturation Methods 0.000 description 5
- 230000036425 denaturation Effects 0.000 description 5
- 238000012257 pre-denaturation Methods 0.000 description 5
- 101710134784 Agnoprotein Proteins 0.000 description 4
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000003415 peat Substances 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 229940027257 timentin Drugs 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 3
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 3
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 3
- 238000003501 co-culture Methods 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000010899 nucleation Methods 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000009331 sowing Methods 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 241000219195 Arabidopsis thaliana Species 0.000 description 2
- 235000011302 Brassica oleracea Nutrition 0.000 description 2
- 244000304217 Brassica oleracea var. gongylodes Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 229920006255 plastic film Polymers 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 241000203069 Archaea Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 238000010356 CRISPR-Cas9 genome editing Methods 0.000 description 1
- 238000010453 CRISPR/Cas method Methods 0.000 description 1
- 241001249699 Capitata Species 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 229910004616 Na2MoO4.2H2 O Inorganic materials 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 238000010459 TALEN Methods 0.000 description 1
- 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000005782 double-strand break Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- -1 imported raw package Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 1
- ISPYRSDWRDQNSW-UHFFFAOYSA-L manganese(II) sulfate monohydrate Chemical compound O.[Mn+2].[O-]S([O-])(=O)=O ISPYRSDWRDQNSW-UHFFFAOYSA-L 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000008263 repair mechanism Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- FDEIWTXVNPKYDL-UHFFFAOYSA-N sodium molybdate dihydrate Chemical compound O.O.[Na+].[Na+].[O-][Mo]([O-])(=O)=O FDEIWTXVNPKYDL-UHFFFAOYSA-N 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to a method for directionally editing common head cabbage genes by using CRISPR/Cas9 and application thereof, belonging to the technical field of biology. The method comprises the steps of designing sgRNA by taking a common head cabbage BoGASA gene sequence as a reference, constructing a sgRNA vector of a BoGASA gene, transforming agrobacterium by recombinant plasmids, mediating genetic transformation of common head cabbage stalk cotyledons and molecular detection of transformed plants, establishing a set of complete common head cabbage gene editing technical system on the basis, and having important significance for developing reverse genetics research of the common head cabbage and analyzing gene functions of other cruciferous plants.
Description
Technical Field
The invention relates to the technical field of biotechnology, in particular to a method for directionally editing common head cabbage genes by using CRISPR/Cas9 and application thereof.
Background
Common head cabbage (Brassica oleracea L. var. capitata L.) belongs to Brassica crops of Brassicaceae, is a variety of cabbage (Brassica oleracea L.), is commonly planted throughout the country, and is one of important vegetables in China. With the rapid development of high-throughput sequencing technology and the disclosure of genome data of common head cabbage, an effective molecular biological means is urgently needed to analyze a large number of unknown functional genes. Compared with model plants such as rice, arabidopsis thaliana, tomatoes and the like, most of horticultural plants lack an effective regeneration system and a genetic transformation system, and the research on the gene function of the horticultural plants is seriously hindered.
The emergence of the CRISPR/Cas9 gene editing technology provides a convenient method for the research of the gene function of the common head cabbage. The system was first discovered in bacteria and archaea as a weapon for cleaving foreign nucleic acids and defending against infection by foreign viruses. The II-type CRISPR/Cas system can be used for directional gene editing after being modified, and the sgRNA guides the targeted cutting of Cas9 protein to cause DNA double-strand break, trigger a non-homologous recombination end connection repair mechanism and realize gene mutation. Compared with the technologies such as ZFN, TALEN and the like, the CRISPR/Cas9 technical vector is simple to construct and easy to operate, and target gene editing can be realized by matching with a perfect plant regeneration system, so that a material with relatively stable heredity is obtained.
Therefore, how to provide a method for directionally editing a common head cabbage gene by using CRISPR/Cas9 is a problem to be solved urgently by those skilled in the art.
Disclosure of Invention
In view of the above, the invention provides a method for directionally editing a common head cabbage gene by using CRISPR/Cas9 and an application thereof.
On the basis, a set of complete gene editing technical system is established, and the method has important significance for development of horticultural plant reverse genetics research and gene function analysis.
In order to achieve the purpose, the invention adopts the following technical scheme:
a method for directionally editing a common head cabbage gene using CRISPR/Cas9, comprising the steps of:
(1) designing and pairing primers: the designed forward and reverse primers and ddH2Preparing reaction liquid by using O, ligase and polynucleotide kinase, and carrying out pairing treatment to obtain a reaction product;
wherein the forward primer sequence is BoGASA-F: 5'-GATTGCTTCCTCACCTCACACAGAA-3', SEQ ID NO. 1;
the reverse primer sequence is BoGASA-R: 5'-AAACTTCTGTGTGAGGTGAGGAAGC-3', SEQ ID NO. 2;
(2) and (3) plasmid digestion: digesting and recovering the psgR-Cas9-At plasmid to obtain a linear plasmid;
(3) connecting: connecting the reaction product obtained in the step (1) and the linear plasmid obtained in the step (2) to obtain a recombinant plasmid;
(4) enzyme digestion, connection and transformation: performing double enzyme digestion on the recombinant plasmid obtained in the step (3) by adopting Hind III and Kpn I to obtain a sgRNA-Cas9 fragment, and connecting the sgRNA-Cas9 fragment with the linearized pCAMBIA1301 to obtain pCAMBIA1301-sgRNA-Cas 9;
(5) genetic transformation: infecting the explant by bacterial liquid containing the plasmid pCAMBIA1301-sgRNA-Cas9 in the step (4) and culturing to obtain a complete plant;
(6) and (3) gene editing plant detection: extracting and editing plant leaf DNA as a template, and carrying out PCR amplification and sequence detection.
Preferably: the step (1) is specifically as follows: mu.L of 100. mu.M forward primer, 1. mu.L of 100. mu.M reverse primer, 1. mu.L of 10 XT 4 DNA ligase buffer, 6.5. mu.L of ddH2O, 0.5 mu L of 10U/mu L T4 polynucleotide kinase, preparing 10 mu L reaction solution, cooling to 25 ℃ at 37 ℃ for 30min and 95 ℃ for 5min, and then cooling to 25 ℃ at 0.2 ℃/s; ddH for reaction products2Diluting by times with O for later use.
Further, the dilution factor was 250-fold.
Preferably: the enzyme in the step (2) is BbsI, and the enzymeThe cutting system is as follows: 20 μ L of psgR-Cas9-At, 10U/. mu.L of BbsI 1 μ L, 10U/. mu.L of bovine small intestine alkaline phosphatase 1 μ L, 4 μ L of 10 XNEBuffer 2.1, 14 μ L of ddH2O。
Further, the enzyme digestion time is 2 h.
Preferably: the step (3) is specifically as follows: mu.L of the linearized plasmid obtained in step (2), 1. mu.L of the reaction product obtained in step (1), 1. mu.L of 10 XT 4 DNA ligase buffer, 1. mu.L of 400U/. mu. L T4 DNA ligase, 6. mu.L of ddH2O, ligation was performed overnight, and the resulting recombinant plasmid was transformed into E.coli, which was cultured on a Mackanka agar medium containing 100. mu.g/mL of ampicillin.
Further: placing at 16 ℃ for connecting overnight; the next day, the recombinant plasmid was transformed into E.coli DH5a, and the cells were plated on 100. mu.g/mL ampicillin Mackanka agar medium and cultured overnight at 37 ℃.
Preferably: the enzyme digestion system in the step (4) is as follows: 25 μ L of plasmid, 5 μ L of 10 XNEB cutSmart Buffer, 20U/. mu.L HindIII-HF 1 μ L, 20U/. mu.L Kpn I-HF1 μ L, plus ddH2O to 50 mu L, and water bath at 37 ℃ for 3 h.
Further, the enzyme digestion product is subjected to 1% agarose gel electrophoresis, and sgRNA-Cas9(5.7kb) and linearized pCAMBIA1301 are recovered after gel cutting;
the ligation reaction system is as follows: mu.L of digested sgRNA-Cas9, 3. mu.L of digested p CAMBIA1301, 1. mu.L of 10 XT 4 ligase buffer, 1. mu. L T4 DNA ligase (400U/. mu.L) (NEB, New England Biolabs, USA), made up to 10. mu.L with water. Ligation was carried out overnight at 16 ℃. The following day, the ligation product was transformed into E.coli DH5a, spread on LB medium containing 50. mu.g/mL kanamycin, and cultured overnight at 37 ℃.
Preferably: the steps (2) and (4) also comprise colony PCR identification of positive clones, and plasmid extraction after correct sequencing, and the specific steps are as follows:
a: with M13F: 5'-TGTAAAACGACGGCCAGT-3', SEQ ID NO.3 and Bo GASA-R primers to perform colony PCR to identify positive clones;
b: selecting positive clones from PCR products, culturing with LB culture solution of 100 mug/mL ampicillin, and sequencing bacterial solution;
c: the clone with correct sequencing is shake-cultured by LB culture solution of 50 mug/mL kanamycin, and plasmid is extracted by a plasmid extraction kit and stored at-20 ℃ for later use.
Further, the colony PCR reaction system is as follows: mu. M M13F 1. mu.L, 10. mu.M Bo GASA-R1. mu.L, 12.5. mu.L 2 XQuick Taq HS DyeMix, 10.5. mu.L ddH2O;
The reaction system is as follows: pre-denaturation at 98 deg.C for 3min, denaturation at 94 deg.C for 30s, annealing at 53 deg.C for 30s, and extension at 72 deg.C for 20s, and circulating for 30 times, and extension at 72 deg.C for 5 min;
selecting positive clones from the PCR products through a 1% agarose gel electrophoresis result, performing shake culture at 37 ℃ overnight by using LB culture solution of 100 mu g/mL ampicillin, and sequencing bacterial solution; clones with correct sequencing were shake-cultured overnight at 37 ℃ in LB medium with 50. mu.g/mL kanamycin, plasmids were extracted with the axygen plasmid extraction kit, and stored at-20 ℃ for further use.
Preferably: the preparation method of the bacterial liquid in the step (5) comprises the following steps:
1) transferring the plasmid obtained in the step (4) into agrobacterium, performing PCR (polymerase chain reaction) identification on positive clone after culture, and shaking the culture solution for later use;
2) and taking the agrobacterium tumefaciens single colony subjected to streak culture, inoculating and shaking culture, centrifugally collecting bacteria, and suspending by using an eluent.
Further, step 1) transferring the plasmid obtained in step (4) into agrobacterium GV3101 by using a freeze-thaw method, carrying out shake culture on the transformed agrobacterium in an antibiotic-free LB culture solution at 28 ℃ for 2-3 h, coating the transformed agrobacterium on an LB solid culture medium plate containing 50 mug/mL rifampicin and 50 mug/mL cana, placing the plate on an LB solid culture medium plate at 28 ℃ for carrying out inversion culture for 48h, carrying out PCR (polymerase chain reaction) to identify positive clone, and shaking the strain with an LB culture solution containing 50 mug/mL rifampicin and 50 mug/mL cana for later use;
2) taking a single agrobacterium colony subjected to streak culture, inoculating the single agrobacterium colony to an LB liquid culture medium containing 50 mu g/mL kanamycin and 50 mu g/mL rifampicin, and performing shake culture overnight at 28 ℃ and 200 rpm; centrifuging the Agrobacterium liquid at 6500rpm and 20 deg.C for 8min the next day, collecting bacteria by three times, and suspending (OD 5.8) with eluent (MS +20g/L sucrose)600Value 0.3).
Preferably: step (5), explant: fully sterilizing common head cabbage seeds, inoculating the seeds to a germination culture medium, and culturing for 5 days under the illumination condition; cutting sterile seedling cotyledon with stalk as explant after 5d, inoculating to pre-culture medium, and pre-culturing for 3d under illumination condition;
infection in step (5): taking the cotyledon with stalk which is pre-cultured for 3d, and infecting the cotyledon with stalk by using the suspended bacterial liquid; inoculating on a co-culture medium, after dark culture for 3d, inoculating the explant on a differentiation medium, and culturing under the illumination condition; and transferring the selected strong resistant bud into a rooting culture medium to grow into a complete plant, and hardening the seedling.
Further, explant:
firstly, sowing seeds, namely, sterilizing a common head cabbage material with 'sweet taste 55' (selected by vegetable research institute of agricultural academy of sciences of Jiangsu province, 2015, identified by crop variety identification of Jiangsu province, identification number: Suzhan cabbage 201511) by 70% alcohol for 1min, then, dropwise adding a tween into a 7% sodium hypochlorite solution for sterilizing for 15min, continuously shaking the mixture to fully sterilize the seeds, washing the seeds with sterile water for three times, putting the seeds on filter paper for sucking dry, sowing the seeds on a germination culture medium (1/2MS +30g/L sucrose +7g/L agar powder pH5.8), and culturing the seeds for 5d under the condition of illumination of 25 ℃ and 16 h;
② explant preculture, cutting the cotyledon with stalk of the aseptic seedling after seeding culture for 5d as explant, placing in preculture medium (MS +30g/L sucrose +7g/L agar powder +2.0 mg/L6-BA +0.05mg/L NAA +7.5mg/L AgNO)3pH5.8), and culturing at 25 deg.C in dark for 1d, and then at 25 deg.C for 2d under 16h light.
Infection: taking the stem-carrying cotyledon pre-cultured for 3d, infecting for 1min with the suspended bacterial liquid, placing on absorbent paper, sucking dry bacterial liquid, and then inoculating to the pre-culture medium (MS +30g/L sucrose +7g/L agar powder +2.0 mg/L6-BA +0.05mg/L NAA +7.5mg/L AgNO)3pH5.8), carrying out co-culture, carrying out dark culture for 3d at 25 ℃, inoculating the explant to a differentiation culture medium (MS +2.0 mg/L6-BA +0.06mg/L NAA +7g/L agar powder +30g/L sucrose +200mg/L timentin +5mg/L hygromycin) after 3d, and carrying out culture under the illumination condition of 25 ℃ for 16 h;
rooting, namely selecting strong resistant buds to be transferred into a rooting culture medium (MS +0.3mg/L NAA +200mg/L timentin +5mg/L hygromycin +30g/L cane sugar +7g/L agar powder pH5.8) for rooting culture, and culturing at the temperature of 25 ℃ for 16h under the illumination condition;
hardening seedlings, opening bottles to train for 24-48 h after rooting of transformed seedlings, carefully washing off a culture medium at roots, inserting the washed culture medium into a moist seedling medium (Danish Topyl peat soil seedling medium, imported original package, peat soil particle size specification of 0-6 mm, water absorption of 80%, pH of 5.5-6), covering and moisturizing by using a plastic film for 1-2 d, then uncovering, and carrying out normal cultivation and management.
Preferably: and (6) gene editing plant detection: taking leaf tissue of a gene editing plant, extracting genome DNA, and performing amplification reaction by using a forward primer: 5'-TATGATGCAGTGAAAGTTCA-3', SEQ ID NO.4 and reverse primer 5'-TTTGATTGCCGGGGACGTCG-3', SEQ ID NO.5 amplify the target sequence; and (3) recovering a PCR product, connecting the recovered fragment to pMD18-T, converting the recovered fragment into Escherichia coli competent DH5a, culturing, picking a single colony, and sequencing.
Further, the amplification system is: 2 XKOD FXNEO Buffer 25. mu.L, 2mM dNTPs 5. mu.L, 10. mu.M forward primer 2. mu.L, 10. mu.M reverse primer 2. mu.L, 1. mu.L common head cabbage genomic DNA template, 14.5. mu.L ddH2O,0.5μL KOD FX NEO(Toyobo);
The PCR reaction system is as follows: pre-denaturation at 95 ℃ for 3min, denaturation at 94 ℃ for 30s, annealing at 53 ℃ for 30s, extension at 72 ℃ for 30s, and extension at 72 ℃ for 5min after 30 cycles;
the PCR product was subjected to 1% agarose gel electrophoresis and then gel-cut for recovery, the recovered fragment was ligated to pMD18-T and transformed into E.coli competent DH5a, the transformed solution was smeared on LB medium of 100. mu.g/mL ampicillin and cultured overnight at 37 ℃, a single colony was picked up, and then shaken turbid at 37 ℃ with LB medium of 100. mu.g/mL ampicillin and sequenced.
The invention also provides a gene editing plant obtained by any one of the methods.
According to the technical scheme, compared with the prior art, the method for directionally editing the common head cabbage gene by using the CRISPR/Cas9 and the application thereof are disclosed, the obtained technical effects provide a regeneration system and a genetic transformation method of the common head cabbage, a set of complete gene editing technical system is established on the basis, and the method has important significance for development of reverse genetics research and gene function analysis of horticultural plants.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, it is obvious that the drawings in the following description are only embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to the provided drawings without creative efforts.
FIG. 1 is a schematic drawing of a portion of the psgR-Cas9-At body provided by the present invention.
FIG. 2 is a schematic diagram of the differentiation culture provided by the present invention, wherein A: aseptic seedlings; b: pre-culturing; c: co-culturing; d: performing differentiation culture; e: resistant buds; f: and (6) rooting.
FIG. 3 is a schematic diagram of gene-editing plant sequencing provided by the invention. Wherein WT represents the sequencing result of the BoGASA gene for the 'sweet 55' common head cabbage without gene editing; -22 represents a deletion of 22 bases from one of the DNA duplexes of the BoGASA gene; +1 represents 1 more bases on the other strand of the DNA duplex of BoGASA.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The embodiment of the invention discloses a method for directionally editing common head cabbage genes by using CRISPR/Cas9 and application thereof.
The raw materials and the kit related in the embodiment are obtained from commercial channels, do not have requirements on brands of the raw materials and the kit, and meet the test requirements, for example, an MS culture medium comprises the following components in 1L:
NH4HO3 33000mg、KNO3 38000mg、CaCl2.2H2O 8800mg、KH2PO4 3400mg、MgSO4.7H2O 7400mg、FeSO4.7H2O 560mg、Na2EDTA 2H2O 460mg、H3BO3 1240 mg、MnSO4.H2O 4460mg、ZnSO4.7H2O 1720mg、Na2MoO4.2H2O 50mg、CuSO4.5H2O 5mg、CoCl2.6H2o5 mg, KI 166mg, inositol 20000mg, glycine 400mg, IVB nicotinic acid 100mg, vitamin B120 mg, vitamin B6100 mg and the balance of sterile water.
1/2MS Medium, calculated as 1L, NH4HO316500mg, and the rest is the same as MS.
The methods not mentioned are all routine laboratory test methods and are not described in detail here.
Example 1
1, primer design:
using the sequence of common head cabbage BoGASA gene (Genbank accession number XM-013767612.1) as an initial sequence, and CRISPR Primer Designer software (https:// onlinestriberry. wiley. com/doi/epdf/10.1111/jipb.12295) is used to design primers, and the sequences of the primers are as follows:
BoGASA-F:5’-GATTGCTTCCTCACCTCACACAGAA-3’,SEQ ID NO.1;
BoGASA-R:5’-AAACTTCTGTGTGAGGTGAGGAAGC-3’,SEQ ID NO.2;
wherein, the forward primer (BoGASA-F) is 20 bases (excluding NGG) before the bases of the GATT + G + BoGASA gene NGG; the reverse primer (BoGASA-R) is the reverse complementary sequence + C20 bases (excluding NGG) before NGG base in AAAC + BoGASA gene.
Example 2
2, gene editing vector construction process:
2.1) primer pairing.
mu.L of 100. mu.M forward primer, 1. mu.L of 100. mu.M reverse primer, 1. mu.L of 10 XT 4 DNA ligase buffer, 6.5. mu.L of ddH2O, 0.5. mu. L T4 Polynucleotide kinase (10U/. mu.L) (NEB, New England Biolabs, USA) 10. mu.L of the reaction solution was prepared, followed by 30min at 37 ℃ and 5min at 95 ℃Reacting, and finally cooling to 25 ℃ at the speed of 0.2 ℃/s. ddH for reaction products2Diluting with O by 250 times for later use.
2.2) shaking of the culture broth containing 100. mu.g/mL ampicillin in LB medium containing psgR-Cas9-At (see FIG. 1 for a schematic of the vector body part, see the full sequence of the vector: liu W, Zhu X, Lei M, et al (2015) A failed procedure for CRISPR/Cas9-media gene editing in Arabidopsis thaliana [ J]Scientific bulletin (English edition), 60(15): 1332-1347.) Escherichia coli. The next day the plasmid was extracted and digested with BbsI at 37 ℃ for 2 h. The enzyme digestion system is as follows: 20 μ L of ps gR-Cas9-At, 1 μ L of BbsI (10U/. mu.L) (NEB, New England Biolabs, USA), 1 μ L of bovine small intestine alkaline phosphatase (10U/. mu.L) (NEB, New England Biolabs, USA), 4 μ L of 10 XNEBuffer 2.1, 14 μ L of ddH2And O. And (3) carrying out electrophoresis on the enzyme digestion product through 1% agarose gel, cutting the gel and recovering.
2.3) ligation. mu.L of the recovered product of step 2.2, 1. mu.L of the reaction product of step 2.1, 1. mu.L of 10 XT 4 DNA ligase buffer, 1. mu. L T4 DNA ligase (400U/. mu.L) (NEB, New England Biolabs, USA), 6. mu.L of ddH2O, and ligated overnight at 16 ℃. The following day, the ligation product was transformed into E.coli DH5a, and spread on 100. mu.g/mL ampicillin Mackanka agar medium and cultured overnight at 37 ℃.
2.4) colony PCR. Positive clones were identified by colony PCR using M13F (5'-TGTAAAACGACGGCCAGT-3', SEQ ID NO.3) and BoGASA-R as primers. The reaction system is as follows: mu. L M13F (10. mu.M), 1. mu.L of BoGASA-R (10. mu.M), 12.5. mu.L of 2 XQuick Taq HS DyeMix (Toyobo), 10.5. mu.L of ddH2O。
The PCR reaction system is as follows: pre-denaturation at 98 deg.C for 3min, denaturation at 94 deg.C for 30s, annealing at 53 deg.C for 30s, and extension at 72 deg.C for 20s, and circulating for 30 times, and extension at 72 deg.C for 5 min. The PCR product was subjected to 1% agarose gel electrophoresis to select positive clones, which were shake-cultured overnight at 37 ℃ in LB medium containing 100. mu.g/mL ampicillin.
Meanwhile, 50. mu.g/mL of LB culture solution containing kanamycin was used to shake culture Escherichia coli containing pCAMBIA1301 plasmid at 37 ℃. The plasmid was extracted with the axygen plasmid extraction kit and stored at-20 ℃ for future use.
2.5) enzyme cutting, connection and transformation. Taking the product of step 2.4The plasmid was digested with Hind III and Kpn I in the following manner: mu.L of plasmid, 5. mu.L of 10 XNEB CutSmart Buffer, 1. mu.L of HindIII-HF (20U/. mu.L) (NEB, New England Biolabs, USA), 1. mu.L of Kpn I-HF (20U/. mu.L) (NEB, New England Biolabs, USA), plus ddH2O to 50. mu.L. Water bath at 37 ℃ for 3 h. After the enzyme digestion product is subjected to 1% agarose gel electrophoresis, the gel is run and cut to recover sgRNA-Cas9(5.7kb) and linearized pCAMBIA 1301.
The ligation reaction system is as follows: mu.L of digested sgRNA-Cas9, 3. mu.L of digested pCAMBIA1301, 1. mu.L of 10x T4 ligase buffer, 1. mu. L T4 DNA ligase (400U/. mu.L) (NEB, New England Biolabs, USA), made up to 10. mu.L with water. Ligation was carried out overnight at 16 ℃. The following day, the ligation product was transformed into E.coli DH5a, spread on LB medium containing 50. mu.g/mL kanamycin, and cultured overnight at 37 ℃.
2.6) colony PCR. Positive clones were identified by colony PCR using M13F (5'-TGTAAAACGACGGCCAGT-3', SEQ ID NO.3) and BoGASA-R as primers. The reaction system is as follows: mu. L M13F (10. mu.M), 1. mu.L of BoGASA-R (10. mu.M), 12.5. mu.L of 2 XQuick Taq HS DyeMix (Toyobo), 10.5. mu.L of ddH2O。
The PCR reaction system is as follows: pre-denaturation at 98 deg.C for 3min, denaturation at 94 deg.C for 30s, annealing at 53 deg.C for 30s, and extension at 72 deg.C for 20s, and circulating for 30 times, and extension at 72 deg.C for 5 min. The PCR product was subjected to 1% agarose gel electrophoresis to select positive clones, which were shake-cultured overnight at 37 ℃ in LB medium of 100. mu.g/mL ampicillin, and the bacterial solution was sequenced. The correctly sequenced clones were shake-cultured overnight at 37 ℃ in LB medium with 50. mu.g/mL kanamycin. The plasmid was extracted with the axygen plasmid extraction kit and stored at-20 ℃ for future use.
2.7) Agrobacterium transformation. Transferring the plasmid obtained in the step 2.6 into agrobacterium GV3101 by a freeze-thaw method, carrying out shake culture on the transformed agrobacterium in an antibiotic-free LB culture solution at 28 ℃ for 2-3 h, coating the transformed agrobacterium on an LB solid culture medium plate containing 50 mug/mL rifampicin and 50 mug/mL cana, and carrying out inverted culture at 28 ℃ for 48 h. Positive clones were identified by PCR, and 50. mu.g/mL rifampicin + 50. mu.g/mL kanamycin was shaken in LB medium for further use.
Example 3
3 culturing and genetic transformation of common head cabbage explant (each step is schematically shown in figure 2, wherein A is aseptic seedling, B is pre-culture, C is co-culture, D is differentiation culture, E is resistant bud, and F is rooting).
3.1) explant preparation:
seeding: sterilizing the common head cabbage material 'sweet 55' with 70% alcohol for 1min, then adding a drop of Tween into 7% sodium hypochlorite solution for 15min, continuously shaking to fully sterilize the seeds, washing with sterile water for three times, placing on filter paper for blotting, sowing in a germination culture medium (1/2MS +30g/L sucrose +7g/L agar powder pH5.8), and culturing for 5d at 25 ℃ under 16h illumination.
Preculture of explants: cutting the cotyledon with stalk of the aseptic seedling after seeding culture for 5 days as explant, and horizontally placing in a pre-culture medium (MS +30g/L sucrose +7g/L agar powder +2.0 mg/L6-BA +0.05mg/L NAA +7.5mg/L AgNO)3pH5.8), and culturing at 25 deg.C in dark for 1d, and then at 25 deg.C for 2d under 16h light.
3.2) preparing bacterial liquid: a single colony of the streaked Agrobacterium was inoculated into LB liquid medium containing 50. mu.g/mL kanamycin and 50. mu.g/mL rifampicin and shake-cultured overnight at 28 ℃ and 200 rpm. Centrifuging the Agrobacterium strain liquid at 6500rpm and 20 deg.C for 8min the next day, collecting bacteria by centrifugation three times, and suspending (OD 5.8) with eluent (MS +20g/L sucrose pH5.8)600Value 0.3).
3.3) Co-culture and differentiation culture: taking the stem-carrying cotyledon pre-cultured for 3d, infecting for 1min with the suspended bacterial liquid, placing on absorbent paper, sucking dry bacterial liquid, and then inoculating to the pre-culture medium (MS +30g/L sucrose +7g/L agar powder +2.0 mg/L6-BA +0.05mg/L NAA +7.5mg/L AgNO)3pH5.8), culturing in dark for 3d at 25 ℃, inoculating the explant to a differentiation medium (MS +2.0 mg/L6-BA +0.06mg/L NAA +30g/L sucrose +7g/L agar powder +200mg/L timentin +5mg/L hygromycin) after 3d, and culturing at 25 ℃ for 16h under illumination.
3.4) rooting: the selected resistant bud with strong growth is transferred into a rooting culture medium (MS +0.3mg/L NAA +200mg/L timentin +5mg/L hygromycin +30g/L sucrose +7g/L agar powder pH5.8) for rooting culture, and the rooting culture is carried out at the temperature of 25 ℃ for 16h under the illumination condition.
3.5) hardening seedlings: opening a bottle to train for 24-48 h after rooting of the transformed seedling, carefully washing off a culture medium at the root, inserting the seedling into a moist seedling substrate (Danish brand Torpu peat soil seedling substrate, imported raw package, peat soil particle size specification of 0-6 mm, water absorption of 80%, pH 5.5-6), covering and moisturizing by using a plastic film for 1-2 d, then uncovering, and carrying out normal cultivation and management.
3.6) statistics of conversion: and after differential culture, counting the selected robust resistant buds for about 4-6 weeks. Per dish resistant bud/explant × 100%, the average conversion of the brassica napus CRISPR-Cas9 vector was 5.84%, see table 1 for details.
TABLE 1 cabbage genetic transformation statistics
Culture dish | Explant | Resistant bud | Conversion rate% | Culture dish | Explant | Resistant bud | Conversion rate% | |
M1 | 41 | 2 | 4.88 | M11 | 40 | 1 | 2.50 | |
M2 | 45 | 3 | 6.67 | M12 | 37 | 3 | 8.11 | |
M3 | 46 | 3 | 6.52 | M13 | 38 | 2 | 5.26 | |
M4 | 42 | 2 | 4.76 | M14 | 31 | 1 | 3.23 | |
M5 | 28 | 1 | 3.57 | M15 | 19 | 0 | 0.00 | |
M6 | 21 | 2 | 9.52 | M16 | 42 | 4 | 9.52 | |
M7 | 35 | 3 | 8.57 | M17 | 25 | 1 | 4.00 | |
M8 | 45 | 2 | 4.44 | M18 | 19 | 2 | 10.53 | |
M9 | 36 | 1 | 2.78 | M19 | 27 | 3 | 11.11 | |
M10 | 42 | 2 | 4.76 | M20 | 33 | 2 | 6.06 | |
Mean value of | 38.1 | 2.1 | 5.65 | Mean value of | 31.1 | 1.9 | 6.03 |
Example 4
4. Gene editing plant detection
Taking leaf tissue of a gene editing plant, extracting genome DNA by using a Kangwei plant genome DNA kit, and amplifying a target sequence by using a forward primer (5'-TATGATGCAGTGAAAGTTCA-3', SEQ ID NO.4) and a reverse primer (5'-TTTGATTGCCGGGGACGTCG-3', SEQ ID NO.5), wherein the amplification system is as follows: 2 XKOD FXNEO Buffer 25. mu.L, 2mM dNTPs 5. mu.L, 10. mu.M forward primer 2. mu.L, 10. mu.M reverse primer 2. mu.L, 1. mu.L common head cabbage genomic DNA template, 14.5. mu.L ddH2O,0.5μL KOD FX NEO(Toyobo)。
The PCR reaction system is as follows: pre-denaturation at 95 deg.C for 3min, denaturation at 94 deg.C for 30s, annealing at 53 deg.C for 30s, and extension at 72 deg.C for 30s, and circulating for 30 times, and extension at 72 deg.C for 5 min. Carrying out gel cutting and recovery on a PCR product after 1% agarose gel electrophoresis, connecting a recovered fragment to pMD18-T, converting Escherichia coli competent DH5a, smearing a conversion solution on an LB culture medium of 100 mu g/mL ampicillin for overnight culture at 37 ℃, picking a single colony, shaking the LB culture medium of 100 mu g/mL ampicillin at 37 ℃ for turbidity, and then carrying out sequencing, wherein the sequencing result is shown in figure 3, wherein WT represents the sequencing result of the BoGASA gene of the kohlrabi 'sweet 55' which is not subjected to gene editing; after the BoGASA genes are edited by using a CRISPR/Cas9 technology, mutant plants have biallelic mutation, and the sequencing result of the biallelic mutation of one mutant plant is-22/+ 1; -22 represents a deletion of 22 bases from one of the DNA duplexes of the BoGASA gene; +1 represents 1 more bases on the other strand of the DNA duplex of BoGASA.
The results show that the target gene of the kohlrabi can be effectively edited according to the method described in the specification.
The embodiments in the present description are described in a progressive manner, each embodiment focuses on differences from other embodiments, and the same and similar parts among the embodiments are referred to each other.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Sequence listing
<110> agricultural science and academy of Jiangsu province
Nanjing Rihua agricultural science and technology Co., Ltd
<120> method for directionally editing common head cabbage gene by using CRISPR/Cas9 and application
<160> 5
<170> SIPOSequenceListing 1.0
<210> 1
<211> 25
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
gattgcttcc tcacctcaca cagaa 25
<210> 2
<211> 25
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
aaacttctgt gtgaggtgag gaagc 25
<210> 3
<211> 18
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
tgtaaaacga cggccagt 18
<210> 4
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
tatgatgcag tgaaagttca 20
<210> 5
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
tttgattgcc ggggacgtcg 20
Claims (10)
1. A method for targeted editing of common head cabbage genes using CRISPR/Cas9, characterized in that the application of the BoGASA gene in the gene editing of common head cabbage comprises the following steps:
(1) designing and pairing primers: the designed forward and reverse primers and ddH2Preparing reaction liquid by using O, ligase and polynucleotide kinase, and carrying out pairing treatment to obtain a reaction product;
wherein the forward primer sequence is BoGASA-F: 5'-GATTGCTTCCTCACCTCACACAGAA-3', SEQ ID NO. 1;
the reverse primer sequence is BoGASA-R: 5'-AAACTTCTGTGTGAGGTGAGGAAGC-3', SEQ ID NO. 2;
(2) and (3) plasmid digestion: digesting and recovering the psgR-Cas9-At plasmid to obtain a linear plasmid;
(3) connecting: connecting the reaction product obtained in the step (1) and the linear plasmid obtained in the step (2) to obtain a recombinant plasmid;
(4) enzyme digestion, connection and transformation: performing double enzyme digestion on the recombinant plasmid obtained in the step (3) by adopting Hind III and Kpn I to obtain a sgRNA-Cas9 fragment, and connecting the sgRNA-Cas9 fragment with the linearized pCAMBIA1301 to obtain pCAMBIA1301-sgRNA-Cas 9;
(5) genetic transformation: infecting the explant by bacterial liquid containing the plasmid pCAMBIA1301-sgRNA-Cas9 in the step (4) and culturing to obtain a complete plant;
(6) and (3) gene editing plant detection: extracting and editing plant leaf DNA as a template, and carrying out PCR amplification and sequence detection.
2. The method for directionally editing common head cabbage genes by using CRISPR/Cas9 according to claim 1, wherein the step (1) is specifically as follows: mu.L of 100. mu.M forward primer, 1. mu.L of 100. mu.M reverse primer, 1. mu.L of 10 XT 4 DNA ligase buffer, 6.5. mu.L of ddH2O, 0.5 mu L of 10U/mu L T4 polynucleotide kinase, preparing 10 mu L reaction solution, cooling to 25 ℃ at 37 ℃ for 30min and 95 ℃ for 5min, and then cooling to 25 ℃ at 0.2 ℃/s; ddH for reaction products2Diluting with O for later use.
3. The method for directionally editing the common head cabbage gene by using the CRISPR/Cas9 as claimed in claim 2, wherein the enzyme in step (2) is BbsI, and the enzyme system is as follows: 20 μ L of psgR-Cas9-At, 10U/. mu.L of BbsI 1 μ L, 10U/. mu.L of bovine small intestine alkaline phosphatase 1 μ L, 4 μ L of 10 XNEBuffer 2.1, 14 μ L of ddH2O。
4. The method for directionally editing common head cabbage genes by using CRISPR/Cas9 according to claim 3, wherein the step (3) is specifically as follows: mu.L of the linearized plasmid obtained in step (2), 1. mu.L of the reaction product obtained in step (1), 1. mu.L of 10 XT 4 DNA ligase buffer, 1. mu.L of 400U/. mu. L T4 DNA ligase, 6. mu.L of ddH2O, ligation was performed overnight, and the resulting recombinant plasmid was transformed into E.coli, which was cultured on a Mackanka agar medium containing 100. mu.g/mL of ampicillin.
5. The method for directionally editing common head cabbage genes by using CRISPR/Cas9 according to claim 4, wherein the enzyme cutting system in step (4) is as follows: 25 μ L of plasmid, 5 μ L of 10 XNEB cutSmart Buffer, 20U/. mu.L HindIII-HF 1 μ L, 20U/. mu.L Kpn I-HF1 μ L, plus ddH2O to 50 mu L, and water bath at 37 ℃ for 3 h.
6. The method for directionally editing common head cabbage genes by using CRISPR/Cas9 as claimed in claim 5, wherein the steps (2) and (4) further comprise colony PCR to identify positive clones, and extracting plasmids after the sequencing is correct, and the specific steps are as follows:
a: M13F: 5'-TGTAAAACGACGGCCAGT-3', SEQ ID NO.3 and BoGASA-R primers to perform colony PCR to identify positive clones;
b: selecting positive clones from PCR products, culturing with LB culture solution of 100 mug/mL ampicillin, and sequencing bacterial solution;
c: the clone with correct sequencing is shake-cultured by LB culture solution of 50 mug/mL kanamycin, and plasmid is extracted by a plasmid extraction kit and stored at-20 ℃ for later use.
7. The method for directionally editing common head cabbage genes by using CRISPR/Cas9 as claimed in claim 6, wherein the preparation method of the bacterial liquid in step (5) comprises the following steps:
1) transferring the plasmid obtained in the step (4) into agrobacterium, performing PCR (polymerase chain reaction) identification on positive clone after culture, and shaking the culture solution for later use;
2) and taking the agrobacterium tumefaciens single colony subjected to streak culture, inoculating and shaking culture, centrifugally collecting bacteria, and suspending by using an eluent.
8. The method for directionally editing common head cabbage genes by using CRISPR/Cas9 according to claim 7, wherein the CRISPR/Cas9 is characterized in that:
step (5) the explant: fully sterilizing common head cabbage seeds, inoculating the seeds to a germination culture medium, and culturing for 5 days under the illumination condition; cutting sterile seedling cotyledon with stalk as explant after 5d, inoculating to pre-culture medium, and pre-culturing for 3d under illumination condition;
infection in step (5): taking the cotyledon with stalk which is pre-cultured for 3d, and infecting the cotyledon with stalk by using the suspended bacterial liquid; inoculating on a co-culture medium, after dark culture for 3d, inoculating the explant on a differentiation medium, and culturing under the illumination condition; and transferring the selected strong resistant bud into a rooting culture medium to grow into a complete plant, and hardening the seedling.
9. The method for directionally editing a common head cabbage gene by using CRISPR/Cas9 according to claim 8, wherein the gene editing plant of step (6) detects that: taking leaf tissue of a gene editing plant, extracting genome DNA, and performing amplification reaction by using a forward primer: 5'-TATGATGCAGTGAAAGTTCA-3', SEQ ID NO.4 and reverse primer 5'-TTTGATTGCCGGGGACGTCG-3', SEQ ID NO.5 amplify the target sequence; and (3) recovering a PCR product, connecting the recovered fragment to pMD18-T, converting the recovered fragment into Escherichia coli competent DH5a, culturing and picking a single colony, shaking the bacteria and sequencing.
10. A gene-edited plant obtained by the method of any one of claims 1 to 9.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010843518.7A CN112063651A (en) | 2020-08-20 | 2020-08-20 | Method for directionally editing common head cabbage gene by using CRISPR/Cas9 and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010843518.7A CN112063651A (en) | 2020-08-20 | 2020-08-20 | Method for directionally editing common head cabbage gene by using CRISPR/Cas9 and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112063651A true CN112063651A (en) | 2020-12-11 |
Family
ID=73661376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010843518.7A Pending CN112063651A (en) | 2020-08-20 | 2020-08-20 | Method for directionally editing common head cabbage gene by using CRISPR/Cas9 and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112063651A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114317561A (en) * | 2021-08-17 | 2022-04-12 | 浙江美之奥种业股份有限公司 | Broccoli gene fixed-point editing method based on CRISPR/Cas9 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107557381A (en) * | 2017-10-12 | 2018-01-09 | 南京农业大学 | A kind of foundation and its application of Chinese cabbage CRISPR Cas9 gene editing systems |
CN108728486A (en) * | 2018-06-20 | 2018-11-02 | 江苏省农业科学院 | A kind of construction method of eggplant CRISPR/Cas9 gene knockout carriers and application |
CN110607322A (en) * | 2019-09-25 | 2019-12-24 | 山西省农业科学院作物科学研究所 | Construction method of CRISPR/Cas9 vector applied to potatoes |
-
2020
- 2020-08-20 CN CN202010843518.7A patent/CN112063651A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107557381A (en) * | 2017-10-12 | 2018-01-09 | 南京农业大学 | A kind of foundation and its application of Chinese cabbage CRISPR Cas9 gene editing systems |
CN108728486A (en) * | 2018-06-20 | 2018-11-02 | 江苏省农业科学院 | A kind of construction method of eggplant CRISPR/Cas9 gene knockout carriers and application |
CN110607322A (en) * | 2019-09-25 | 2019-12-24 | 山西省农业科学院作物科学研究所 | Construction method of CRISPR/Cas9 vector applied to potatoes |
Non-Patent Citations (7)
Title |
---|
CUNFA MA, CHENZENG ZHU, MIN ZHENG, MENGCI LIU, DEJUN ZHANG, BAOLI LIU, QINFEI LI, JUN SI, XUESONG REN, HONGYUAN SONG: "CRISPR/Cas9-mediated multiple gene editing in Brassica oleracea var. capitata using the endogenous tRNA-processing system" * |
刘询;张斌;李浪;刘春林;阮颖;: "甘蓝型油菜BnaLCR23基因CRISPR-Cas9表达载体的构建及遗传转化" * |
李东昊;姜玲;刘春林;阮颖;: "甘蓝型油菜BnaSDG8基因CRISPR/Cas9敲除载体的构建及功能探究" * |
杨慧;胡信畅;次央;阮颖;刘春林;: "甘蓝型油菜BnaABI4基因CRISPR/Cas9编辑载体的构建及甘蓝型油菜转化" * |
王肖红;曾爱松;高兵;宋立晓;严继勇;: "结球甘蓝不定芽诱导及遗传转化的影响因子" * |
马存发: "利用CRISPR/Cas9技术编辑甘蓝基因的初步研究" * |
马晓丽;景巧丽;裴雁曦;: "基于CRISPR/Cas9技术的大白菜内源硫化氢生成酶LCD基因突变体构建" * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114317561A (en) * | 2021-08-17 | 2022-04-12 | 浙江美之奥种业股份有限公司 | Broccoli gene fixed-point editing method based on CRISPR/Cas9 |
CN114317561B (en) * | 2021-08-17 | 2024-01-09 | 浙江美之奥种业股份有限公司 | CRISPR/Cas 9-based broccoli gene fixed-point editing method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106957855B (en) | Method for targeted knockout of rice dwarf gene SD1 by using CRISPR/Cas9 technology | |
WO2020007331A1 (en) | Method for site-specific mutagenesis of medicago sativa gene by using crispr/cas9 system | |
CN100429310C (en) | Gene for controlling paddy tillering and usage | |
AU2019297209B2 (en) | Method of obtaining multi-leaf alfalfa material by means of MsPALM1 artificial site-directed mutant | |
US11365423B2 (en) | Method of obtaining multileaflet Medicago sativa materials by means of MsPALM1 artificial site-directed mutants | |
CN117004649B (en) | Agrobacterium-mediated broom corn millet efficient genetic transformation method | |
CN113265403A (en) | Soybean Dt1 gene editing site and application thereof | |
CN112063651A (en) | Method for directionally editing common head cabbage gene by using CRISPR/Cas9 and application | |
CN108165578B (en) | Efficient preparation method for mutant aiming at multiple members of same gene family of cabbage mustard simultaneously | |
CN114350673B (en) | Rice KOB1 gene for regulating and controlling seed vigor and regulating and controlling method thereof | |
CN113699165B (en) | Nucleic acid for reducing height of corn strain and application thereof | |
CN116024253A (en) | Agrobacterium rhizogenes mediated editing method for amaranthus spinosus hairy root genome | |
CN108424910B (en) | RNA fragment for target gene interference and application thereof | |
CN116769799B (en) | Soybean mutant gene for improving yield of leguminous crops and application thereof | |
CN113151352B (en) | Transgenic method of octaploid rape and application in gene editing | |
CN114591984B (en) | Application of OsAP79 gene in inducing rice to resist brown planthoppers | |
CN114958866B (en) | Gene for regulating soybean branch number and application thereof | |
KR102573947B1 (en) | Gene editing system for increasing of soybean gene editing efficiency and uses thereof | |
CN116515853B (en) | Ryegrass salt-tolerant gene LpNAC022 and application thereof | |
Jin et al. | Regeneration and Genetic Transformation of Arabidopsis Pumila: An Ephemeral Plant Suitable for Investigating the Mechanisms for Adaptation to Desert Environments | |
CN113862282A (en) | Soybean PCL homologous gene editing site and application thereof | |
CN118086362A (en) | Application of rice gene OsALDO in regulation of rice grain type and mutant thereof | |
CN116751787A (en) | Tobacco nicotine metabolism related transcription factor NtbHLH66 and encoding gene, RNAi interference vector and application thereof | |
CN116410285A (en) | Tobacco transcription factor NtbHLH68 and application of coded protein thereof in anabolism of nicotine | |
CN116676329A (en) | Cloning and expression vector construction method of oil tea SQS gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201211 |